Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer

Clinical trial NCT04963283 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04963283
Sponsor: University of Colorado, Denver
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Adenocarcinoma Colon Cancer Colon Adenocarcinoma Rectum Cancer Rectal Cancer Rectal Adenocarcinoma Colorectal Cancer

Start date: 2021-06-23
Primary completion: 2026-02-24
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.